CJC-1295 + Ipamorelin

CJC-1295 and Ipamorelin activate separate receptor systems in the GH axis — GHRH receptors and GHS-R1a (ghrelin) receptors respectively. Because there is no receptor overlap and no competition between the two, they work simultaneously and produce synergistic GH output. Research models consistently show that the combined GH pulse from both peptides is larger and more sustained than either alone. The combination is widely used in GH axis research, studied for body composition, connective tissue repair, sleep architecture, and age-related GH decline (somatopause) models. Not for human consumption — for research use only.

CJC-1295 without DAC (also called Modified GRF 1-29 or Mod GRF 1-29) is a truncated, tetra-substituted GHRH analogue with a half-life of approximately 30 minutes. It mimics physiological pulsatile GHRH signalling, triggering discrete GH pulses. CJC-1295 with DAC includes a Drug Affinity Complex modification that binds plasma albumin, extending the half-life to 6–8 days and creating a prolonged, non-pulsatile GHRH signal. Our blend uses CJC-1295 without DAC to preserve the pulsatile GH release pattern most relevant to physiological GH axis research. Not for human consumption — for research use only.

The pre-blended format offers three advantages: convenience (single reconstitution vs two separate vials), consistency (co-lyophilised peptides are uniformly distributed so each draw contains the correct 1:1 ratio), and cost-efficiency. The blend is ideal for researchers following a fixed 1:1 CJC-1295:Ipamorelin protocol. Researchers requiring asymmetric ratios or independent dosing schedules of each compound should purchase Ipamorelin 10mg separately. Not for human consumption — for research use only.

Reconstitution: Draw 1–2mL of bacteriostatic water into a clean 31G insulin syringe. Inject slowly down the inside wall of the blend vial. Gently swirl until fully dissolved — do not shake. The solution should be clear and colourless. With 1mL BAC water: 10mg/mL total (5mg/mL CJC-1295 + 5mg/mL Ipamorelin). Storage: Lyophilised — store at −20°C for up to 24 months. Reconstituted — refrigerate at 2–8°C and use within 28 days. Our BAC Water 10mL and Insulin Needles 31G are available for a complete setup.

Both CJC-1295 and Ipamorelin are legal to purchase in Australia for legitimate laboratory research purposes. Neither is listed as a scheduled substance under the Poisons Standard when sold for research use only. Purchasers must be 18+ and confirm research-only use. These compounds are not TGA-approved for human consumption, therapeutic, or veterinary use. Our blend is independently verified at 99.0% HPLC purity with full COA documentation.

Peptide Warehouse Australia dispatches CJC-1295 + Ipamorelin nationwide via Australia Post with full tracking from our Melbourne warehouse. Orders placed before 12PM AEST dispatch the same business day; orders after 12PM AEST dispatch the next business day. Standard Post (2–6 business days) $8.99; Express Post (1–3 business days) $13.99. Free shipping on orders over $199 AUD. All orders are shipped in discreet plain packaging.

The CJC-1295 + Ipamorelin combination is used in GH axis research including: pulsatile GH secretion quantification and IGF-1 elevation studies, body composition research in rodent models (lean tissue and lipid metabolism), sleep architecture and nocturnal GH pulse timing experiments, age-related GH decline (somatopause) research, muscle and connective tissue repair models, and metabolic rate and lipolysis pathway investigations. The combination is the standard dual-pathway GH secretagogue protocol in preclinical and in-vitro research. Not for human consumption — for research use only.

CJC-1295 with DAC (drug affinity complex) binds albumin to extend half-life substantially, while CJC-1295 without DAC (often called Mod GRF 1-29) has a much shorter action studied for pulsatile release. Researchers select the version matching their protocol; confirm which your experiment requires before ordering. Not for human consumption — for research use only.

CJC-1295 is a GHRH analogue and Ipamorelin is a ghrelin-receptor secretagogue — they act on two different receptors of the growth-hormone axis, so the combination is studied for complementary stimulation in research models. The two pathways together are the focus of this blend's research use. Not for human consumption — for research use only.

Research with GHRH-analogue plus secretagogue combinations examines growth-hormone release dynamics and downstream IGF-1 signalling in preclinical models. These are mechanistic research endpoints; the blend is supplied strictly for in-vitro laboratory research and is not TGA-approved. Not for human consumption — for research use only.

This is a combined research blend of CJC-1295 and Ipamorelin, often shortened to CJC/Ipa or CJC-1295 + Ipa. The CJC-1295 component is the no-DAC (mod GRF 1-29) form. For in-vitro research use only.